Clinical Trial Update: Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating irinotecan plus E7820 versus FOLFIRI in second-line locally advanced or metastatic colon or rectal cancer; study terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Rectal Cancer

Drugs mentioned

• E7820
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Eisai Inc. | Conditions: Colon Cancer, Rectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-11-25